INTS vs MAS
Intensity Therapeutics, Inc. Common stock (INTS) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
INTS currently screens at market cap $7.7M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the INTS and MAS stock pages for the full models.
Not investment advice.